| Financial Year |
March 31 2023 |
| Monetary Funds |
259,117,500.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
106,279,594.77 |
| Advances to Suppliers |
278,902,079.62 |
| Other Receivables |
27,812,672.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,800,371,633.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
551,916,144.03 |
| Total Current Assets |
3,031,598,865.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
663,916,778.39 |
| Long-term Equity Investment |
50,787,256.57 |
| Investment Properties |
32,796,043.67 |
| Fixed Assetes |
20,931,555,895.84 |
| Under-construction Projects |
5,981,555,570.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,291,318,565.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
464,903,252.68 |
| Deferred Income Tax Assets |
540,234,931.97 |
| Other Non-Current Assets |
1,327,127,861.89 |
| Sub-Total of Non-Current Assets |
32,286,231,579.71 |
| Total Assets |
35,317,830,444.76 |
| Short-Term Loans |
5,928,389,027.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,297,077.06 |
| Accounts Payable |
1,462,839,674.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
130,978,382.21 |
| Taxes Payable |
122,057,053.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
325,858,870.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,144,415,935.53 |
| Other Current Liabilities |
2,056,010,527.49 |
| Sub-Total of Current Liabilities |
12,697,471,830.95 |
| Long-term Loans |
856,500,000.00 |
| Bonds Payable |
2,740,000,000.00 |
| Long-Term Accounts Payable |
220,843,487.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,276,000.00 |
| Deferred Income Tax Liabilities |
505,666,485.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,821,119,958.23 |
| Total Liabilities |
17,518,591,789.18 |
| Paid-In Capital(Or Share Stock) |
1,919,676,011.00 |
| Capital Surplus |
4,956,785,872.06 |
| Surplus Reserve |
1,009,643,662.01 |
| LESS:Treasury Stock |
115,361,930.00 |
| Undistributed Profits |
9,846,399,419.76 |
| Minority Stockholder's Interest |
125,680,632.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,673,558,023.06 |
| Owner's Equity（Stockholder's Equity） |
17,799,238,655.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,317,830,444.76 |
